Levetiracetam-induced interstitial lung disease in a patient with advanced lung cancer

An 85-year-old woman with antibiotics-resistant pneumonia after surgery for metastatic brain tumor from lung cancer was consulted to our department. Chest CT showed diffuse GGO bilaterally. BALF showed elevated ratios of lymphocytes and CD4/CD8. Tests for bacteria, mycobacteria, and fungi were negat...

Full description

Bibliographic Details
Main Authors: Shintaro Sato, Tomohiro Oba, Hiroki Ohta, Yuta Tsukahara, Gen Kida, Emiri Tsumiyama, Kenji Kusano, Tomotaka Nishizawa, Rie Kawabe, Hideaki Yamakawa, Keiichi Akasaka, Masako Amano, Hidekazu Matsushima
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Respiratory Medicine Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S221300712030455X
_version_ 1818380818642370560
author Shintaro Sato
Tomohiro Oba
Hiroki Ohta
Yuta Tsukahara
Gen Kida
Emiri Tsumiyama
Kenji Kusano
Tomotaka Nishizawa
Rie Kawabe
Hideaki Yamakawa
Keiichi Akasaka
Masako Amano
Hidekazu Matsushima
author_facet Shintaro Sato
Tomohiro Oba
Hiroki Ohta
Yuta Tsukahara
Gen Kida
Emiri Tsumiyama
Kenji Kusano
Tomotaka Nishizawa
Rie Kawabe
Hideaki Yamakawa
Keiichi Akasaka
Masako Amano
Hidekazu Matsushima
author_sort Shintaro Sato
collection DOAJ
description An 85-year-old woman with antibiotics-resistant pneumonia after surgery for metastatic brain tumor from lung cancer was consulted to our department. Chest CT showed diffuse GGO bilaterally. BALF showed elevated ratios of lymphocytes and CD4/CD8. Tests for bacteria, mycobacteria, and fungi were negative. She improved following levetiracetam discontinuance and systemic corticosteroid administration, and we diagnosed levetiracetam-induced lung injury. Although levetiracetam is widely used, few reports of levetiracetam-induced pneumonia exist. Changes in chest images may occur after levetiracetam administration if patients have multiple risk factors for development of drug-induced interstitial lung disease. Bronchoscopy is useful for differential diagnosis if new lung lesions appear after starting levetiracetam.
first_indexed 2024-12-14T02:24:44Z
format Article
id doaj.art-73d1decad5bb45839288ecbbdb39c2dd
institution Directory Open Access Journal
issn 2213-0071
language English
last_indexed 2024-12-14T02:24:44Z
publishDate 2020-01-01
publisher Elsevier
record_format Article
series Respiratory Medicine Case Reports
spelling doaj.art-73d1decad5bb45839288ecbbdb39c2dd2022-12-21T23:20:25ZengElsevierRespiratory Medicine Case Reports2213-00712020-01-0131101241Levetiracetam-induced interstitial lung disease in a patient with advanced lung cancerShintaro Sato0Tomohiro Oba1Hiroki Ohta2Yuta Tsukahara3Gen Kida4Emiri Tsumiyama5Kenji Kusano6Tomotaka Nishizawa7Rie Kawabe8Hideaki Yamakawa9Keiichi Akasaka10Masako Amano11Hidekazu Matsushima12Corresponding author. Department of Respiratory Medicine, Saitama Red Cross Hospital, 1-5 Shintoshin, Chuo-ku, Saitama, 330-8553, Japan.; Department of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, JapanDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, JapanDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, JapanDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, JapanDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, JapanDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, JapanDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, JapanDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, JapanDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, JapanDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, JapanDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, JapanDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, JapanDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, JapanAn 85-year-old woman with antibiotics-resistant pneumonia after surgery for metastatic brain tumor from lung cancer was consulted to our department. Chest CT showed diffuse GGO bilaterally. BALF showed elevated ratios of lymphocytes and CD4/CD8. Tests for bacteria, mycobacteria, and fungi were negative. She improved following levetiracetam discontinuance and systemic corticosteroid administration, and we diagnosed levetiracetam-induced lung injury. Although levetiracetam is widely used, few reports of levetiracetam-induced pneumonia exist. Changes in chest images may occur after levetiracetam administration if patients have multiple risk factors for development of drug-induced interstitial lung disease. Bronchoscopy is useful for differential diagnosis if new lung lesions appear after starting levetiracetam.http://www.sciencedirect.com/science/article/pii/S221300712030455XDrug-induced interstitial lung diseaseLevetiracetamLung cancer
spellingShingle Shintaro Sato
Tomohiro Oba
Hiroki Ohta
Yuta Tsukahara
Gen Kida
Emiri Tsumiyama
Kenji Kusano
Tomotaka Nishizawa
Rie Kawabe
Hideaki Yamakawa
Keiichi Akasaka
Masako Amano
Hidekazu Matsushima
Levetiracetam-induced interstitial lung disease in a patient with advanced lung cancer
Respiratory Medicine Case Reports
Drug-induced interstitial lung disease
Levetiracetam
Lung cancer
title Levetiracetam-induced interstitial lung disease in a patient with advanced lung cancer
title_full Levetiracetam-induced interstitial lung disease in a patient with advanced lung cancer
title_fullStr Levetiracetam-induced interstitial lung disease in a patient with advanced lung cancer
title_full_unstemmed Levetiracetam-induced interstitial lung disease in a patient with advanced lung cancer
title_short Levetiracetam-induced interstitial lung disease in a patient with advanced lung cancer
title_sort levetiracetam induced interstitial lung disease in a patient with advanced lung cancer
topic Drug-induced interstitial lung disease
Levetiracetam
Lung cancer
url http://www.sciencedirect.com/science/article/pii/S221300712030455X
work_keys_str_mv AT shintarosato levetiracetaminducedinterstitiallungdiseaseinapatientwithadvancedlungcancer
AT tomohirooba levetiracetaminducedinterstitiallungdiseaseinapatientwithadvancedlungcancer
AT hirokiohta levetiracetaminducedinterstitiallungdiseaseinapatientwithadvancedlungcancer
AT yutatsukahara levetiracetaminducedinterstitiallungdiseaseinapatientwithadvancedlungcancer
AT genkida levetiracetaminducedinterstitiallungdiseaseinapatientwithadvancedlungcancer
AT emiritsumiyama levetiracetaminducedinterstitiallungdiseaseinapatientwithadvancedlungcancer
AT kenjikusano levetiracetaminducedinterstitiallungdiseaseinapatientwithadvancedlungcancer
AT tomotakanishizawa levetiracetaminducedinterstitiallungdiseaseinapatientwithadvancedlungcancer
AT riekawabe levetiracetaminducedinterstitiallungdiseaseinapatientwithadvancedlungcancer
AT hideakiyamakawa levetiracetaminducedinterstitiallungdiseaseinapatientwithadvancedlungcancer
AT keiichiakasaka levetiracetaminducedinterstitiallungdiseaseinapatientwithadvancedlungcancer
AT masakoamano levetiracetaminducedinterstitiallungdiseaseinapatientwithadvancedlungcancer
AT hidekazumatsushima levetiracetaminducedinterstitiallungdiseaseinapatientwithadvancedlungcancer